|
Chinese Market Research Report of Meropenem its Competitive products Publisher: Beijing Orientbit Technology Co., Ltd. Format: Adobe PDF Price: 3,000$ Contact:Ms. Wu huifang Mr. Bian Chenghua Tel.: 86-10-68032463 Fax: 86-10-68052505 E-mail: xuezhe@healthoo.com leigy@healthoo.com
Contents 1、General situation of Carbapenem series 1.1、The history of the products 1.2、Trend review of the different products 2、Market analysis of Meropenem its competitive products in China 2.1、Market size growth trend from 2013 to 2019 2.2、Market share trend for different products from 2013 to 2019 2.3、Market share change trend of Meropenem from 2013 to 2019 2.4、Manufacturer's brshare change trend of "Penem series" from 2013 to 2019 2.5、Latest bid winning price of "Penem series" procurement 2.6、Quality Consistency Evaluation for Generic Drugs 3、API intermediates of Meropenem 3.1、Supply & Demand 3.2、Analysis of API manufacturers 4、Other new products 4.1、Tebipenem 4.2、Doripenem 4.3、Banipenem 5、Market trend opportunity in policy environment of Quality Consistency Evaluation & GPO 5.1、The impact of price changes on the market 5.2、Future development trend
Table 1 Global listed Carbapenem products Table 2 The list for obtain approval number of Meropenem domestic import As of April 2020 Table 3 List of "Penem series" for basic medical insurance published in August 2019 Table 4 Market size for "Penem series" from 2013 to 2019 Table 5 Market size Average growth rate of different from 2013 to 2019 Table 6 Annual growth rate of sales of six kinds of "Peinan" products in 2013-2019 Table 7 Meropenem hospital sales quantity, price amount change comparison (sampling figures） Table 8 Sales amount changes of competitors of Meropenem (sampling figures) (total of all specifications) Table 9 Sales amount changes of competitors of Meropenem (sampling figures) (different specifications) Table 10 Sales Quantity changes of competitors of Meropenem (sampling figures) (total of all specifications) Table 11 Sales Quantity changes of competitors of Meropenem (sampling figures) (different specifications) Table 12 Price changes of competitors of Meropenem (sampling figures) (different specifications) Table 13 Sales amount of different manufacturer's brfrom 2013 to 2019 Table 14 Sales amount of product by different company from 2013 to 2019 Table 15 Winning enterprises prices of special centralized purchase of "Penem series" drugs in Hunan Province in Apr, 2020 Table 16 Information of "Penem series" products manufacturers in the list of drug examine from 2015 to Apr, 2020 Table 17 Supply & Demof API intermediate Table 18 Export statistics of API Intermediates Table 19 Statistics of export varieties of "Penem series" Table 20 Exporters of 4-AA in 2019 Table 21 Exporters of Meropenem API Aseptic powder in 2019 Table 22 d enterprise of Tebipenem as of April 2020 Table 23 d enterprise of Doripenem as of April 2020
Graph 1 Market size growth rate of "Penem series" from 2013 to 2019 Graph 2 Market share by Value of different products from 2013 to 2019 Graph 3 Comparison of sales quantity price change of 2013-2019 Meropenem (sampling figures) for specification: 0.5g Graph 4 Meropenem competitor share of amount from 2013 to 2019(sampling figures） Graph 5 Market share of amount by different manufacturer's brfrom 2013 to 2019 Graph 6 Market share of amount by different competitors in 2019 Graph 7 Export Quantity of "Penem series" API intermediates from 2013 to 2019 Graph 8 Export Amount of "Penem series" API intermediates from 2013 to 2019 Graph 9 The share of export quantity of different products Graph 10 The export price of 4-AA used for nucleus ($/kg) Graph 11 The price of Meropenem injection in hospital from 2013 to 2019 (RMB/bottle)
|
